October 05, 2020
A Federal Circuit judge peppered Vectura Limited's counsel with tough questioning Monday, suggesting that attorneys for the U.K.-based pharmaceutical company defied a Delaware federal court's instructions during jury trial last year, which may warrant a retrial of the nearly $107 million verdict in an inhaler patent dispute.
September 12, 2019
A Delaware federal judge on Thursday granted British pharma company Vectura's request for $10.5 million in supplemental damages in a case in which a jury found GlaxoSmithKline willfully infringed a patent covering inhalers, though the judge denied Vectura's bid for an additional $33 million in enhanced damages.
June 27, 2019
British pharma company Vectura has asked a Delaware federal judge to pile another nearly $44 million onto the damages GlaxoSmithKline owes after a jury found GSK willfully infringed a patent covering inhalers, saying the company is still selling the products and doesn't plan to stop.
June 14, 2019
Vectura Ltd. won an $89.7 million patent infringement verdict against GlaxoSmithKline LLC by relying on flawed tests and inflating damages, GSK has told a Delaware federal judge in hopes of undoing its loss.
May 03, 2019
A federal jury in Delaware on Friday found that GlaxoSmithKline LLC and Glaxo Group Ltd. owe $89.7 million to U.K.-based Vectura Limited for infringing a single claim of a patent covering features of three important Glaxo inhalers for treating chronic obstructive pulmonary disease.